The Role of Age on Beta-Amyloid1–42 Plasma Levels in Healthy Subjects

The Role of Age on Beta-Amyloid1–42 Plasma Levels in Healthy Subjects

Beta-amyloid (Aβ) plaques have been observed in the brain of healthy elderlies with frequencies strongly influenced by age. The aim of the study is to evaluate the role of age and other biochemical and hematological parameters on Aβ1–42 plasma levels in cognitively and neurologically normal individu...

Full description

Bibliographic Details
Main Authors:	Chiara Zecca, Giuseppe Pasculli, Rosanna Tortelli, Maria Teresa Dell’Abate, Rosa Capozzo, Maria Rosaria Barulli, Roberta Barone, Miriam Accogli, Serena Arima, Alessio Pollice, Vincenzo Brescia, Giancarlo Logroscino
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Aging Neuroscience
Subjects:	beta amyloid Alzheimer’s disease biomarker age plasma
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2021.698571/full

Similar Items

Plasma Inflammatory Cytokines Are Elevated in ALS
by: Rosanna Tortelli, et al.
Published: (2020-11-01)

A New Presenilin 1 (Psen1) Mutation (p.Cys263Trp) as a Cause of Both Early and Late-Onset Alzheimer’s Disease in a Large Italian Family
by: Rosanna Tortelli, et al.
Published: (2021-06-01)

The Italian Version of the Test Your Memory (TYM-I): A Tool to Detect Mild Cognitive Impairment in the Clinical Setting
by: Maria Rosaria Barulli, et al.
Published: (2021-01-01)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
by: Noelia Fandos, et al.
Published: (2017-01-01)

Redox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro
by: Nima Sasanian, et al.
Published: (2020-06-01)

Prognostic Role of CSF β-amyloid 1–42/1–40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis
by: Tiziana Colletti, et al.
Published: (2021-02-01)

Mitochondrial Disruption by Amyloid Beta 42 Identified by Proteomics and Pathway Mapping
by: Patricia Sinclair, et al.
Published: (2021-09-01)

Matriptase cleaves the amyloid-beta peptide 1–42 at Arg-5, Lys-16, and Lys-28
by: Li-Mei Chen, et al.
Published: (2019-01-01)

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
by: Inge M. W. Verberk, et al.
Published: (2020-09-01)

FNDC5/Irisin System in Neuroinflammation and Neurodegenerative Diseases: Update and Novel Perspective
by: Patrizia Pignataro, et al.
Published: (2021-02-01)

A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics
by: Al- Ayadhi Laila Y, et al.
Published: (2012-01-01)

Abstract OR-14: Fibril Structure and Interface Polymorphism of Amyloid-ß(1-42)
by: Gunnar F. Schröder
Published: (2019-06-01)

Tyramine and Amyloid Beta 42: A Toxic Synergy
by: Sudip Dhakal, et al.
Published: (2020-05-01)

Effect of Aggregated β-Amyloid (1-42) on Synaptic Plasticity of Hippocampal Dentate Gyrus Granule Cells in Vivo
by: Shirin Babri, et al.
Published: (2012-12-01)

High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis
by: Andrea Sturchio, et al.
Published: (2021-08-01)

Effect of Varying Concentrations of Docosahexaenoic Acid on Amyloid Beta (1–42) Aggregation: An Atomic Force Microscopy Study
by: Brenda Yasie Lee, et al.
Published: (2018-11-01)

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42
by: Seong Soo A. An, et al.
Published: (2017-10-01)

Inhibitory Mechanism for Amyloid β42 Aggregation by Catechol-type Flavonoids
by: Sato, Mizuho
Published: (2014)

Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42
by: Ruitian Liu, et al.
Published: (2005-10-01)

Functional Mammalian Amyloids and Amyloid-Like Proteins
by: Maria S. Rubel, et al.
Published: (2020-08-01)

Lower CSF Amyloid-Beta<sub>1–42</sub> Predicts a Higher Mortality Rate in Frontotemporal Dementia
by: Daniela Vieira, et al.
Published: (2019-10-01)

AFM Probing of Amyloid-Beta 42 Dimers and Trimers
by: Sibaprasad Maity, et al.
Published: (2020-04-01)

Divergent Synthesis of scyllo-Inositol Aldoxime Derivatives as Potential Inhibitors of Amyloid-Beta(1-42) Aggregate Formation
by: Chio, Song Ngai
Published: (2010)

Divergent Synthesis of scyllo-Inositol Aldoxime Derivatives as Potential Inhibitors of Amyloid-Beta(1-42) Aggregate Formation
by: Chio, Song Ngai
Published: (2010)

Derivation of cutoffs for the Elecsys® amyloid β (1–42) assay in Alzheimer's disease
by: Leslie M. Shaw, et al.
Published: (2018-01-01)

Aggregation of Mouse Serum Amyloid A Protein Was Promoted by Amyloid-Enhancing Factors with the More Genetically Homologous Serum Amyloid A
by: Xuguang Lin, et al.
Published: (2021-01-01)

Revisiting Cu(II) Bound Amyloid-β40 and Amyloid-β42 Peptides: Varying Coordination Chemistries
by: Orkid Coşkuner-Weber
Published: (2018-08-01)

Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
by: Dietmar Rudolf Thal, et al.
Published: (2019-11-01)

Sensory impairments and cognitive disorders in older age
by: Giancarlo Logroscino, et al.
Published: (2017-10-01)

Insights into Mechanisms of Amyloid Toxicity: Molecular Dynamics Simulations of the Amyloid andbeta-peptide (Aandbeta) and Islet Amyloid Polypeptide (IAPP)
by: Brown, Anne M.
Published: (2016)

Design and Construction of Large Amyloid Fibers
by: Devin M. Ridgley, et al.
Published: (2015-04-01)

Recent Advances by In Silico and In Vitro Studies of Amyloid-β 1-42 Fibril Depicted a S-Shape Conformation
by: Daniel Miguel Ángel Villalobos Acosta, et al.
Published: (2018-08-01)

The Acute Effects of Amyloid-Beta1–42 on Glutamatergic Receptor and Transporter Expression in the Mouse Hippocampus
by: Jason H. Y. Yeung, et al.
Published: (2020-01-01)

Sodium phenylbutyrate reverses lysosomal dysfunction and decreases amyloid-β42 in an in vitro-model of inclusion-body myositis
by: Anna Nogalska, et al.
Published: (2014-05-01)

Admission Levels of Total Tau and β-Amyloid Isoforms 1–40 and 1–42 in Predicting the Outcome of Mild Traumatic Brain Injury
by: Iftakher Hossain, et al.
Published: (2020-05-01)

Disease Transmission by Misfolded Prion-Protein Isoforms, Prion-Like Amyloids, Functional Amyloids and the Central Dogma
by: Martin L. Daus
Published: (2016-01-01)

A β-Amyloid(1-42) Biosensor Based on Molecularly Imprinted Poly-Pyrrole for Early Diagnosis of Alzheimer’s Disease
by: Rezvan Dehdari Vais, et al.
Published: (2021-04-01)

Amyloid Cardiomyopathy: All that Sparkles is Amyloid
by: Abhinav Saxena, et al.
Published: (2016-01-01)

Stability of Plasma Amyloid-β 1–40, Amyloid-β 1–42, and Total Tau Protein over Repeated Freeze/Thaw Cycles
by: Huei-Chun Liu, et al.
Published: (2020-03-01)

Diagnostic Utility of Selected Serum Dementia Biomarkers: Amyloid β-40, Amyloid β-42, Tau Protein, and YKL-40: A Review
by: Karolina Wilczyńska, et al.
Published: (2020-10-01)